Are the results of RTOG 0617 mysterious?

International Journal of Radiation Oncology Biology Physics

Volumn 82, Issue 3, 2012, Pages 1042-1044

  Cox, James D ^a  

^a UNIVERSITY OF TEXAS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER SURGERY; CANCER SURVIVAL; CLINICAL PROTOCOL; EDITORIAL; HISTOGRAM; HUMAN; INTENSITY MODULATED RADIATION THERAPY; INTERMETHOD COMPARISON; LUNG NON SMALL CELL CANCER; META ANALYSIS (TOPIC); METASTASIS FREE SURVIVAL; MINIMAL RESIDUAL DISEASE; ONCOLOGY; OVERALL SURVIVAL; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; RADIATION DOSE; RADIATION RESPONSE; RANDOMIZED CONTROLLED TRIAL (TOPIC); TREATMENT FAILURE;

CARCINOMA, NON-SMALL-CELL LUNG; CAUSE OF DEATH; EARLY TERMINATION OF CLINICAL TRIALS; HEART; HUMANS; LUNG; LUNG NEOPLASMS; RADIATION INJURIES; RADIOTHERAPY DOSAGE; RADIOTHERAPY, INTENSITY-MODULATED; RANDOMIZED CONTROLLED TRIALS AS TOPIC;

EID: 84856392903     PISSN: 03603016     EISSN: 1879355X     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2011.12.032     Document Type: Editorial

References (20)

1. Bradley J, Paulus R, Komaki R, et al. A randomized phase III comparison of standard-dose (60 Gy) versus high-dose (74 Gy) conformal chemoradiotherapy +/- cetuximab for stage IIIa/IIIb non-small cell lung cancer: Preliminary findings on radiation dose in RTOG 0617 (late-breaking abstract 2). Presented at the 53rd Annual Meeting of the American Society of Radiation Oncology, October 2-6, 2011, Miami, FL.
2. M.J. Matthews, S. Kanhouwa, and J. Pickren Frequency of residual and metastatic tumor in patients undergoing curative surgical resection for lung cancer Cancer Chemother Rep 4 1973 63 67
3. Lung Cancer Study Group Effects of post-operative mediastinal radiation on completely resected stage II and stage III epidermoid cancer of the lung N Engl J Med 315 1986 1377 1381
4. PORT Meta-analysis Trialists Group Postoperative radiotherapy in non-small cell lung cancer: Systematic review and meta-analysis of individual patient data from nine randomized controlled trials Lancet 352 1998 257 263
5. B. Dautzenberg, R. Arriagada, A.B. Chammard Groupe d'Etude et de Traitement des Cancers Bronchiques A controlled study of postoperative radiotherapy for patients with completely resected nonsmall cell lung carcinoma Cancer 86 1999 265 273
6. M. Machtay, J.H. Lee, and J.B. Shrager Risk of death from intercurrent disease is not excessively increased by modern postoperative radiotherapy for high-risk resected non-small-cell lung carcinoma J Clin Oncol 19 2001 3912 3917
7. LE/II trials of fractionation in radiation therapy for cancer J Natl Cancer Inst 83 1991 1065 1071
8. J.D. Cox, N. Azarnia, and R.W. Byhardt A randomized phase I/II trial of hyperfractionated radiation therapy with total doses of 60.0 Gy to 79.2 Gy in favorable patients with Radiation Therapy Oncology Group stage III non-small-cell lung carcinoma: Report of Radiation Therapy Oncology Group 83-11 J Clin Oncol 8 1990 1543 1555
9. M.V. Graham, J.A. Purdy, and B. Emami Preliminary results of a prospective trial using three-dimensional radiotherapy for lung cancer Int J Radiat Oncol Biol Phys 33 1995 993 1000
10. L.C. Fang, R. Komaki, and P. Allen Comparison of outcomes for patients with medically inoperable stage I non-small cell lung cancer treated with two-dimensional versus three-dimensional radiotherapy Int J Radiat Oncol Biol Phys 66 2006 108 116
11. Y. Seppenwoolde, H. Shirato, and K. Kitamura Precise and real-time measurement of 3D tumor motion in lung due to breathing and heartbeat, measured during radiotherapy Int J Radiat Oncol Biol Phys 53 2002 822 834
12. H. Shirato, K. Suzuki, and G.C. Sharp Speed and amplitude of lung tumor motion precisely detected in four-dimensional setup and in real-time tumor-tracking radiotherapy Int J Radiat Oncol Biol Phys 64 2006 1229 1236
13. H.H. Liu, P. Balter, and T. Tutt Assessing respiration-induced tumor motion and internal target volume using four-dimensional computed tomography for radiotherapy of lung cancer Int J Radiat Oncol Biol Phys 68 2007 531 540
14. R.W. Underberg, F.J. Lagerwaard, and B.J. Slotman Use of maximum intensity projections (MIP) for target volume generation in 4DCT scans for lung cancer Int J Radiat Oncol Biol Phys 63 2005 253 260
15. E. Rietzel, T. Pan, and G.T. Chen Four-dimensional computed tomography: Image formation and clinical protocol Med Phys 32 2005 874 889
16. International Commission on Radiation Units and Measurements Prescribing, recording, and reporting photon beam therapy (supplement to ICRU report 50): ICRU report 62 1999 ICRU Bethesda, MD
17. A.J. Mundt, and J.C. Roeske Intensity Modulated Radiation Therapy: A Clinical Perspective 2005 BC Decker Toronto
18. S.S. Yom, Z. Liao, and H.H. Liu Initial evaluation of treatment-related pneumonitis in advanced-stage non-small-cell lung cancer patients treated with concurrent chemotherapy and intensity-modulated radiotherapy Int J Radiat Oncol Biol Phys 68 2007 94 102
19. J.D. Bradley, J. Moughan, and M.V. Graham A phase I/II radiation dose escalation study with concurrent chemotherapy for patients with inoperable stages I to III non-small-cell lung cancer: Phase I results of RTOG 0117 Int J Radiat Oncol Biol Phys 77 2010 367 372
20. J.D. Bradley, K. Bae, and M.V. Graham Primary analysis of the phase II component of a phase I/II dose intensification study using three-dimensional conformal radiation therapy and concurrent chemotherapy for patients with inoperable non-small-cell lung cancer: RTOG 0117 J Clin Oncol 28 2010 2475 2480